» Articles » PMID: 20650522

Prevention of HIV Infection for People Who Inject Drugs: Why Individual, Structural, and Combination Approaches Are Needed

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2010 Jul 24
PMID 20650522
Citations 210
Authors
Affiliations
Soon will be listed here.
Abstract

HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individual-level approaches to prevention of HIV infection; review global and regional coverage of opioid substitution treatment, needle and syringe programmes, and antiretroviral treatment; model the effect of increased coverage and a combination of these three approaches on HIV transmission and prevalence in injecting drug users; and discuss evidence for structural-level interventions. Each intervention alone will achieve modest reductions in HIV transmission, and prevention of HIV transmission necessitates high-coverage and combined approaches. Social and structural changes are potentially beneficial components in a combined-intervention strategy, especially when scale-up is difficult or reductions in HIV transmission and injection risk are difficult to achieve. Although further evidence is needed on how to optimise combinations of interventions in different settings and epidemics, we know enough now about which actions are effective: the challenge is to deliver these well and to scale.

Citing Articles

Social determinants of injection drug use-associated bacterial infections and treatment outcomes: systematic review and meta-analysis.

Brothers T, Lewer D, Bonn M, Kim I, Comeau E, Figgatt M medRxiv. 2024; .

PMID: 39398993 PMC: 11469356. DOI: 10.1101/2024.09.20.24313898.


Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers.

Morozova O, Kornilova M, Makarenko O, Antoniak S, Liulchuk M, Varetska O J Int AIDS Soc. 2024; 27 Suppl 3:e26319.

PMID: 39030884 PMC: 11258450. DOI: 10.1002/jia2.26319.


Primary, Secondary, and Tertiary Prevention of Substance Use Disorders through Socioecological Strategies.

Latimore A, Salisbury-Afshar E, Duff N, Freiling E, Kellett B, Sullenger R NAM Perspect. 2024; 2023.

PMID: 38784638 PMC: 11114594. DOI: 10.31478/202309b.


Effect of HIV and substance use disorder comorbidity on the placenta, fetal and maternal health outcomes: systematic review and meta-analysis protocol.

Sorato M, Alemu T, Toma A, Paulos G, Mekonnen S BMJ Open. 2024; 14(5):e083037.

PMID: 38772595 PMC: 11110607. DOI: 10.1136/bmjopen-2023-083037.


Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?.

Dellamura P, Meteliuk A, Fomenko T, Rozanova J Front Public Health. 2024; 11:1259488.

PMID: 38239802 PMC: 10794633. DOI: 10.3389/fpubh.2023.1259488.